Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/25 20:06 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Chan Mitchell | MD | D | 1 | M.d | 0 | 0.00 | 0 | 3 | 3 | D | ||||||||||||||||
4/1/25 16:55 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Goldman Jonathan | MD | D | 1 | M.d | 0 | 0.00 | 0 | 3 | 3 | D | ||||||||||||||||
4/1/25 16:44 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Truex Samantha | MD | D | 1 | M.d | 0 | 0.00 | 0 | 3 | 3 | D | ||||||||||||||||
4/1/25 16:37 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Kantoff Aaron | MD | D | 1 | M.d | 0 | 0.00 | 0 | 3 | 3 | D | ||||||||||||||||
4/1/25 16:30 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Kaplan Gilla | MD | D | 1 | M.d | 0 | 0.00 | 0 | 3 | 3 | D | ||||||||||||||||
4/1/25 16:22 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Almenoff June Sherie | MD | D | 1 | M.d | 0 | 0.00 | 0 | 3 | 317 | 4 | D | |||||||||||||||
4/1/25 16:11 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Sullivan Christopher Ryan | MD | O | CFO | 1 | M.d | 0 | 0.00 | 0 | 24 | 17 | D | |||||||||||||||
4/1/25 16:01 | 3/28/25 | AVTX | Health | Drug | Pharmaceutical Preparations | Neil Garry Arthur | MD | O | CEO | 1 | M.d | 0 | 0.00 | 0 | 65 | 47 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |